Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment

    Qin Xiao, Yongzhou Lu, Wei Yao, Chengchen Gong, Chuanlong Jia, Guojun Jin, Jing Guo, Tianwen Qiu, Yebin Jiang, Min Huang, Wenhua Chu, Qiannan Xu, Nan Xu
    Image of study
    TLDR Molybdenum nanoparticles could be a new treatment for hair loss, working differently than minoxidil.
    The study "Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment through Antioxidant Pathways that Differ from Minoxidil" explores the potential of molybdenum (Mo) nanoparticles in treating alopecia. The researchers hypothesized that Mo nanoparticles could promote hair growth by reducing oxidative stress and accelerating minoxidil-treated hair growth by upregulating SULT and sulfate transfer. To test this, they synthesized Mo nanoparticles and applied them to hair-removed mice. The results suggest that Mo nanoparticles could be a potential treatment for alopecia, offering a different mechanism from the FDA-approved treatment, minoxidil, which has a relatively low efficacy of 30-40%. The study was conducted on seven-week-old male C57BL/6 mice, divided into different treatment groups.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results

    Related Community Posts Join

    1 / 1 results

      community M19 shed after 1yr on dutasteride

      in Finasteride/Dutasteride  23 upvotes 1 week ago
      A 19-year-old male experienced hair shedding after one year on dutasteride and is considering adding topical minoxidil despite scalp itching. Users suggest continuing dutasteride, maintaining a consistent hair routine, and possibly increasing minoxidil dosage.

    Related Research

    2 / 2 results